Prescribing Limitations

Updated 4/4/2019

Q. Can a physician write a controlled substance prescription for himself?

A. No.201 KAR 9:260

Q. What are the prescribing limitations for CII stimulants?

A. Physicians may only prescribe CII amphetamine or amphetamine-like substances to treat:

  • Narcolepsy

  • Attention deficit/hyperactivity disorder

  • Resistant depression disorder in conjunction with antidepressants

  • Drug-induced brain dysfunction

  • Investigational use that has been approved by the Kentucky Board of Medical Licensure

  • Adults with moderate to severe binge-eating disorder

  • May not be used to treat obesity

201 KAR 9:016 Section 3

Q. What are the prescribing limitations for physicians for CIII anorectics?

A. 201 KAR 9:016

Q. Does the patient’s bmi have to be recorded on a phentermine prescription?

A. No.

Q. What are the prescribing limitations for physicians for buprenorphine?

A. 201 KAR 9:270

Q. Can an APRN prescribe buprenorphine?

A. The 2016 Comprehensive Addiction and Recovery Act (CARA) extended the prescribing of buprenorphine in office-based settings to APRNs, who may obtain a DATA waiver number (an X DEA) to treat up to 30 patients after completing 24 hours of required training. An APRN may prescribe transdermal (Butrans) and buccal film (Belbuca) or buprenorphine in the form of brands and generics of buprenorphine single entity products and buprenorphine/naloxone combination products for an off label use (such as pain).  201 KAR 20:065

Prescribing Limitations